首页|司美格鲁肽联合二甲双胍在T2DM合并缺铁性贫血血糖控制中的应用效果

司美格鲁肽联合二甲双胍在T2DM合并缺铁性贫血血糖控制中的应用效果

Effects of Semaglutide Combined with Metformin on Blood Glucose Con-trol in Patients with Type 2 Diabetes Mellitus Complicated with Iron Defi-ciency Anemia

扫码查看
目的 探究2型糖尿病(type 2 diabetes mellitus,T2DM)合并缺铁性贫血患者血糖控制中二甲双胍联合司美格鲁肽的应用价值.方法 回顾性选取2021年1月—2024年1月泉州市第一医院收治的90例T2DM合并缺铁性贫血患者的临床资料,按照不同治疗方式分为两组,各45例.参照组采用二甲双胍治疗,观察组采用二甲双胍与司美格鲁肽联合治疗,比较组间治疗前、后血糖水平、胰岛功能、临床疗效.结果 治疗前,两组血糖水平、胰岛功能比较,差异无统计学意义(P均>0.05);治疗3个月后,观察组血糖水平低于对照组,差异有统计学意义(P<0.05).治疗3个月后,观察组空腹胰岛素水平、胰岛素抵抗指数低于对照组,胰岛β细胞功能指数高于对照组,差异有统计学意义(P均<0.05).观察组临床疗效高于对照组,差异有统计学意义(P<0.05).结论 T2DM合并缺铁性贫血患者血糖控制中二甲双胍基础上加用司美格鲁肽,血糖水平及胰岛功能均可改善,疗效显著.
Objective To investigate the application value of semaglutide combined with metformin in blood glucose control in patients with type 2 diabetes mellitus(T2DM)complicated with iron deficiency anemia.Methods The clini-cal data of 90 patients with T2DM combined with iron deficiency anemia admitted to Quanzhou First Hospital from January 2021 to January 2024 were retrospectively selected and divided into two groups according to different treat-ment methods,with 45 cases in each group.Control group using metformin treatment,observation group with metfor-min and semaglutide combined treatment,the blood glucose level,islet function and clinical curative effect were com-pared before and after treatment between the two groups.Results Before treatment,there were no statistically signifi-cant differences in blood glucose level and islet function between the two groups(both P>0.05).After 3 months of treatment,the blood glucose level of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).After 3 months of treatment,the fasting insulin level and home-ostatic model as-sessment of insulin resistance index of the observation group were lower than those of the control group,and home-ostatic model assessment of islet β-cell function index was higher than that of the control group,and the differences were statistically significant(all P<0.05).The clinical efficacy of the observation group was higher than that of the con-trol group,and the difference was statistically significant(P<0.05).Conclusion In the blood glucose control of T2DM patients with iron deficiency anemia,the addition of semaglutide on the basis of metformin can improve the blood glu-cose level and islet function,and the effect is significant.

Type 2 diabetes mellitusIron deficiency anemiaMetforminSemaglutideBlood glucose controlIslet function

王晓容、黄义霞、陈小青

展开 >

泉州市第一医院血液内科,福建 泉州 362000

2型糖尿病 缺铁性贫血 二甲双胍 司美格鲁肽 血糖控制 胰岛功能

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(9)
  • 9